NMC
NEA Management Company’s Mersana Therapeutics MRSN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-5,959,520
| Closed | -$111M | – | 59 |
|
2020
Q3 | $111M | Sell |
5,959,520
-2,000,000
| -25% | -$37.2M | 4.7% | 6 |
|
2020
Q2 | $186M | Sell |
7,959,520
-4,004,129
| -33% | -$93.7M | 7.49% | 2 |
|
2020
Q1 | $69.7M | Hold |
11,963,649
| – | – | 3.64% | 11 |
|
2019
Q4 | $68.6M | Hold |
11,963,649
| – | – | 3.24% | 12 |
|
2019
Q3 | $18.9M | Buy |
11,963,649
+69,382
| +0.6% | +$110K | 1.57% | 20 |
|
2019
Q2 | $48.2M | Hold |
11,894,267
| – | – | 3.37% | 11 |
|
2019
Q1 | $62.6M | Buy |
11,894,267
+3,750,000
| +46% | +$19.7M | 3.25% | 11 |
|
2018
Q4 | $33.2M | Hold |
8,144,267
| – | – | 1.32% | 14 |
|
2018
Q3 | $81.4M | Hold |
8,144,267
| – | – | 3.51% | 10 |
|
2018
Q2 | $145M | Hold |
8,144,267
| – | – | 6.81% | 5 |
|
2018
Q1 | $128M | Hold |
8,144,267
| – | – | 5.71% | 5 |
|
2017
Q4 | $134M | Hold |
8,144,267
| – | – | 5.54% | 4 |
|
2017
Q3 | $141M | Hold |
8,144,267
| – | – | 4.93% | 2 |
|
2017
Q2 | $114M | Buy |
+8,144,267
| New | +$114M | 4.14% | 2 |
|